Literature DB >> 12028823

Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease.

Michael Munzar1, Suzanna Levy, Robert Rush, Paul Averback.   

Abstract

AD7C-NTP (neural thread protein) is a approximately 41-kD brain protein that is selectively elevated in Alzheimer disease (AD). AD7C-NTP is associated with the pathologic changes of AD, and overexpression of the AD7C-NTP gene is associated with cell death similar to that found in the AD brain. A newly developed competitive ELISA (enzyme-linked immunosorbent assay) was tested in urine samples from patients with AD, patients with non-AD dementia, and healthy normal individuals. Mean assay measurement in the AD group (30.1 +/- 10.8) was significantly higher than in the non-AD dementia control group (13.4 +/- 3.4) and in the nondementia control group (14.8 +/- 5.2) (P <.001). Mean assay measurement in early-AD cases (25.3 +/- 7.6) was significantly lower than in other AD cases (33.9 +/- 11.4). Levels of more than 18 units were found in 89% of overall AD cases and in 10% of overall controls. The results further validate urinary AD7C-NTP as a biochemical marker for AD and indicate that the competitive ELISA-format AD7C-NTP test in urine is an accurate method for determining AD7C-NTP levels in AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028823     DOI: 10.1162/15268740252769709

Source DB:  PubMed          Journal:  Neurol Clin Neurophysiol        ISSN: 1526-8748


  9 in total

1.  Development of a Novel Urine Alzheimer-Associated Neuronal Thread Protein ELISA Kit and Its Potential Use in the Diagnosis of Alzheimer's Disease.

Authors:  Lina Ma; Rong Wang; Ying Han; Shuli Sheng; Jianan Zhu; Zhijuan Ji; Zhiwei Zhao; Ziqing Cao; Peichang Wang
Journal:  J Clin Lab Anal       Date:  2015-06-03       Impact factor: 2.352

Review 2.  Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

Authors:  Yongyao Fu; Deming Zhao; Lifeng Yang
Journal:  J Mol Neurosci       Date:  2014-06-25       Impact factor: 3.444

Review 3.  Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.

Authors:  Panagiotis Zis; Andre Strydom
Journal:  Free Radic Biol Med       Date:  2017-09-01       Impact factor: 7.376

Review 4.  Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

5.  Prospective large-scale field study generates predictive model identifying major contributors to colony losses.

Authors:  Merav Gleit Kielmanowicz; Alex Inberg; Inbar Maayan Lerner; Yael Golani; Nicholas Brown; Catherine Louise Turner; Gerald J R Hayes; Joan M Ballam
Journal:  PLoS Pathog       Date:  2015-04-13       Impact factor: 6.823

Review 6.  A literature review of AD7c-ntp as a biomarker for Alzheimer's disease.

Authors:  Jian Zhang; Shengliang Shi
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

7.  Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Nan Zhang; Liling Zhang; Yan Li; Marc L Gordon; Li Cai; Ying Wang; Mengya Xing; Yan Cheng
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  The association between urinary Alzheimer-associated neuronal thread protein and cognitive impairment in late-life depression: a controlled pilot study.

Authors:  Qing-E Zhang; Sihai Ling; Peng Li; Saina Zhang; Chee H Ng; Gabor S Ungvari; Liang-Jen Wang; Sheng-Yu Lee; Gang Wang; Yu-Tao Xiang
Journal:  Int J Biol Sci       Date:  2018-08-10       Impact factor: 6.580

9.  Brain type carnosinase in dementia: a pilot study.

Authors:  Cynthia M Balion; Carolyn Benson; Parminder S Raina; Alexandra Papaioannou; Christopher Patterson; Afisi S Ismaila
Journal:  BMC Neurol       Date:  2007-11-05       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.